Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

AXT Lowers Q2 Sales Guidance from $20.000M-$22.000M to $17.500M-$18.000M vs $20.852M Est

Author: Benzinga Newsdesk | July 09, 2025 04:16pm
AXT (NASDAQ:AXTI) lowers Q2 sales outlook from $20.000 million-$22.000 million to $17.500 million-$18.000 million vs $20.852 million estimate.

Posted In: AXTI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist